“Can the regulation of reevaluation for modified drugs be improved?”

Although the pharmaceutical industry raised a voice towards preferential regulations for global expansion, such as standard relaxation of reevaluation on incrementally modified drugs, it seems it still needs more time to find improvements.

On the 28^th, the Korean Society of Food, Drug and Cosmetics Regulatory Sciences(KFDC, President Bum-jin Lee) held a forum, ‘Preferential Regulations and Im...